Edaravone: Advances on cytoprotective effects, pharmacological properties, and mechanisms of action.

Saved in:
Bibliographic Details
Title: Edaravone: Advances on cytoprotective effects, pharmacological properties, and mechanisms of action.
Authors: Dakroub F; Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon., Awada B; The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida., Abdelhady S; Faculty of Medicine, Alexandria University, Alexandria, Egypt., Shaito AA; Biomedical Research Center (BRC) and Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Qatar; Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Qatar., Eid AH; Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Qatar., Walker J; Center for Neurotrauma, Multiomics & Biomarkers, Department of Neurobiology and Neuroscience Institute, Morehouse School of Medicine (MSM), Atlanta, Georgia., Mondello S; Biomedical and Dental Sciences and Morphofunctional Imaging, Faculty of Medicine and Surgery, University of Messina, Messina, Italy., Bondi CO; Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, Pennsylvania; Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, Pennsylvania; Center for Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania., Moro F; Department of Acute Brain and Cardiovascular Injury, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy., Elgendy B; Department of Anesthesiology, Washington University in St. Louis, St. Louis, Missouri; Center for Clinical Pharmacology, Washington University School of Medicine and University of Health Sciences & Pharmacy, St. Louis, Missouri., Wang KK; Center for Neurotrauma, Multiomics & Biomarkers, Department of Neurobiology and Neuroscience Institute, Morehouse School of Medicine (MSM), Atlanta, Georgia., Zanier ER; Department of Acute Brain and Cardiovascular Injury, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy. Electronic address: elisa.zanier@marionegri.it., Mechref Y; Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas. Electronic address: yehia.mechref@ttu.edu., Kobeissy F; Center for Neurotrauma, Multiomics & Biomarkers, Department of Neurobiology and Neuroscience Institute, Morehouse School of Medicine (MSM), Atlanta, Georgia. Electronic address: firasko@gmail.com.
Source: Pharmacological reviews [Pharmacol Rev] 2026 Jan; Vol. 78 (1), pp. 100101. Date of Electronic Publication: 2025 Oct 26.
Publication Type: Journal Article; Review
Journal Info: Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: Netherlands NLM ID: 0421737 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0081 (Electronic) Linking ISSN: 00316997 NLM ISO Abbreviation: Pharmacol Rev Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1521-0081
DOI:10.1016/j.pharmr.2025.100101